======= ZNF292 ======= == Gene Information == * **Official Symbol**: ZNF292 * **Official Name**: zinc finger protein 292 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23036|23036]] * **UniProt**: [[https://www.uniprot.org/uniprot/O60281|O60281]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF292&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF292|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616213|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a growth hormone-dependent, zinc finger transcription factor that functions as a tumor suppressor. Naturally occurring mutations in this gene are associated with gastric cancer, colorectal cancer, and chronic lymphocytic leukemia. [provided by RefSeq, May 2017]. * **UniProt Summary**: May be involved in transcriptional regulation. No Pfam Domain information is available for this gene. |DNA-binding transcription activator activity, RNA polymerase II-specific| |positive regulation of transcription by RNA polymerase II| |DNA binding| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp502|Milciclib 2μM R08 exp502]]|-2.58| |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|-2.58| |[[:results:exp532|TIC10 10μM R08 exp532]]|-2.52| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.28| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-2.23| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|-2.2| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.93| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|-1.85| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|-1.82| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|-1.78| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|1.79| |[[:results:exp293|Myriocin 25μM R06 exp293]]|1.88| |[[:results:exp504|MK2206 4μM R08 exp504]]|1.92| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.16| |[[:results:exp352|Dexamethasone 0.006 to 0.015μM on day4 R07 exp352]]|3.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 19036 * **Expression level (log2 read counts)**: 6.89 {{:chemogenomics:nalm6 dist.png?nolink |}}